Orchestra Biomed Holdings, Inc. (OBIO)
4.74
-0.21
(-4.24%)
USD |
NASDAQ |
Sep 03, 16:00
4.725
-0.02
(-0.32%)
After-Hours: 20:00
Orchestra Biomed Holdings Research and Development Expense (TTM) : 63.22M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.22M |
| March 31, 2026 | 60.48M |
| December 31, 2025 | 58.18M |
| September 30, 2025 | 52.33M |
| June 30, 2025 | 49.90M |
| March 31, 2025 | 47.17M |
| December 31, 2024 | 42.80M |
| September 30, 2024 | 40.34M |
| Date | Value |
|---|---|
| June 30, 2024 | 37.31M |
| March 31, 2024 | 34.68M |
| December 31, 2023 | 33.82M |
| September 30, 2023 | 32.85M |
| June 30, 2023 | 30.20M |
| March 31, 2023 | 26.72M |
| December 31, 2022 | 21.94M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Accuray, Inc. | 37.80M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 60.33M |
| ResMed, Inc. | 378.28M |
| Rockwell Medical, Inc. | -- |